Purchase Order 15B51926P00000043
- Not listed
- McKesson Corporation, a major healthcare services and pharmaceutical distribution company based in Irving, Texas, received a $1,364.70 purchase order from the Federal Correctional Complex Pollock on November 17, 2025. This Firm Fixed Price purchase order, designated as MCKESSON PO A249 for Open Market Ensure, represents a non-competed award with no set-aside designation. The contract's place of performance is located in Irving, Texas, reflecting McKesson's operational footprint as a large...
- McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company based in Irving, Texas, was awarded a purchase order valued at $3,660.55 by the Federal Correctional Complex Pollock under the Department of Justice's Bureau of Prisons. This firm fixed-price purchase order, designated as REGULAR MEDS PO 3711, was awarded on November 17, 2025, with an ultimate completion date of the same day. The contract represents a non-competitive award with no set-aside...
- McKesson Corporation was awarded a Firm Fixed Price Purchase Order (OPEN MKT PO 3709) by the Federal Correctional Complex Pollock, a civilian facility under the Bureau of Prisons, with a ceiling value of $1,330.30. The award, issued on September 30, 2026, with an ultimate completion date of the same day, represents a direct procurement with no set-aside designation. Performance is scheduled to occur in Irving, Texas, McKesson's headquarters location, where the company maintains significant...
- McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, was awarded a Firm Fixed Price purchase order valued at $7,338.40 by the Federal Correctional Complex Pollock on November 14, 2025. The contract, designated as Controlled Subs Order PO 3714, represents a non-competed award with an ultimate completion date of November 17, 2025, and will be performed in Irving, Texas. This purchase order falls under the civilian...
- McKesson Corporation was awarded a $20,030.93 firm fixed-price Purchase Order for regular medications to support the Federal Correctional Complex Pollock, a civilian facility within the Bureau of Prisons under the Department of Justice. The purchase order, issued on November 17, 2025, with an ultimate completion date of the same day, represents a non-competitive award with no set-aside designation. Performance will be delivered to Irving, Texas, leveraging McKesson's extensive experience as a...
- This delivery order, valued at $15,282.08, was awarded to McKesson Corporation on September 30, 2026, by the Federal Correctional Complex Pollock, a civilian facility under the Bureau of Prisons. The contract employs firm fixed-price pricing with no set-aside designation and is scheduled for completion by September 30, 2026. Performance will be executed in Irving, Texas, where McKesson maintains its corporate headquarters. As a large business prime contractor, McKesson will deliver...
- The Department of Justice Bureau of Prisons Federal Correctional Complex Pollock awarded McKesson Corporation a firm fixed price purchase order valued at approximately $1,291 for pharmaceutical products. McKesson will provide the pharmaceuticals to the Bureau of Prisons facility in Irving, Texas between December 21-30, 2023. As the parent company of McKesson Drug Company, McKesson Corporation will serve as the prime contractor on this contract to supply pharmaceuticals for the Federal...
- This delivery order, valued at $3,377.78, was awarded on September 30, 2026, to McKesson Corporation for provision of pharmaceutical and medical supplies to the Federal Correctional Complex Pollock, a civilian correctional facility operated by the Bureau of Prisons under the Department of Justice. The contract is structured as a firm fixed-price delivery order with no set-aside designation, reflecting McKesson's status as a large business contractor. Performance will take place in Irving, Texas,...
- Mckesson Corporation will deliver pharmaceuticals to the Federal Correctional Complex Pollock under a $1,881.57 firm fixed price purchase order awarded by the Department of Justice Bureau of Prisons (DOJ-BOP). Performance will occur in Irving, Texas over a one-day period concluding on August 31, 2023. As one of the largest federal correctional facilities, FCC Pollock houses over 5,000 inmates and likely utilizes significant pharmaceutical supplies to support daily medical operations. No...
- The Department of Justice Bureau of Prisons Federal Correctional Complex Pollock awarded McKesson Corporation a firm fixed price purchase order valued at approximately $1,028 for pharmaceutical products. McKesson will deliver the pharmaceuticals to the correctional facility located in Irving, Texas between December 19-30, 2023. As the parent company of McKesson Drug Company, McKesson Corporation will serve as the prime contractor on this contract to provide pharmaceuticals for the Bureau of...
On November 14, 2025, the Federal Correctional Complex Pollock, a civilian agency under the Department of Justice's Bureau of Prisons, awarded an Open Market Purchase Order (PO 3713) to McKesson Corporation for $5,845.60 under a firm fixed-price contract type. The purchase order, with an ultimate completion date of November 17, 2025, represents a routine procurement of pharmaceutical and medical supplies to support correctional facility operations. No set-aside designation was used in this competition. The place of performance is Irving, Texas, where McKesson maintains its corporate headquarters and primary distribution operations. McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company, serves as the prime contractor on this award. The company has an extensive history of federal contracting with the Bureau of Prisons, providing controlled and non-controlled medications, medical consumables, and specialty pharmaceuticals to correctional facilities nationwide. This particular purchase order exemplifies McKesson's ongoing role as a critical supplier of medical and pharmaceutical products to federal correctional institutions, leveraging the company's established infrastructure and government vendor relationships to support healthcare delivery within the federal prison system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 11/14/25 |